Literature DB >> 10218464

Malignant peripheral nerve sheath tumours associated with von Recklinghausen's neurofibromatosis.

R C Ramanathan1, J M Thomas.   

Abstract

AIMS: A retrospective study was conducted of patients with von Recklinghausen's neurofibromatosis who developed malignant peripheral nerve sheath tumours to determine their clinical characteristics, treatment outcome and prognostic factors.
METHODS: During the period 1987-1995, 29 patients with von Recklinghausen's neurofibromatosis (VRN) were seen at the Royal Marsden Hospital, of whom 23 had malignant peripheral nerve sheath tumours (MPNSTs).
RESULTS: The median age of the patients with MPNSTs was 30 years and the sex distribution was equal. The commonest site was the lower extremity, with a tendency for tumours to occur in the proximal parts. A nerve of origin was identified in 59% of the tumours and heterologous differentiation was present in 26%. Multiple primary MPNSTs occurred in four patients (17%) and other malignant tumours developed in three (13%). The overall 5-year survival was 35% with a median survival of 36 months. The incidence of local recurrence was 38% and 75% of them occurred within 2 years.
CONCLUSIONS: MPNSTs which develop in association with VRN occur in a younger age group, tend to be of a higher histological grade and are associated with a very poor prognosis. Tumour size > or = 10 cm (P=0.003) and high tumour grade (P=0.003) were adverse independent prognostic factors for overall survival.

Entities:  

Mesh:

Year:  1999        PMID: 10218464     DOI: 10.1053/ejso.1998.0625

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  20 in total

1.  Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors.

Authors:  Christian Hagel; Ulrich Zils; Matthias Peiper; Lan Kluwe; Stefan Gotthard; Reinhard E Friedrich; David Zurakowski; Andreas von Deimling; Victor Felix Mautner
Journal:  J Neurooncol       Date:  2006-11-17       Impact factor: 4.130

2.  Acute monocular blindness resulting from transformation of von Recklinghausen's neurofibromatosis to malignant melanocytic schwannomas.

Authors:  Stephen H Wrzesinski; Konstantin H Dragnev; Lorna K Mayo; Brent T Harris; Jonathan D Marotti
Journal:  J Neurooncol       Date:  2006-02       Impact factor: 4.130

3.  A retroperitoneal NF1-independent malignant peripheral nerve sheath tumor with elevated serum CA125: case report and discussion.

Authors:  Bing Yan; Xianze Meng; Bian Shi; Jun Shi; Zhifeng Qin; Pinkang Wei
Journal:  J Neurooncol       Date:  2012-04-19       Impact factor: 4.130

4.  18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off.

Authors:  Johannes Salamon; Simon Veldhoen; Ivayla Apostolova; Peter Bannas; Jin Yamamura; Jochen Herrmann; Reinhard E Friedrich; Gerhard Adam; Victor F Mautner; Thorsten Derlin
Journal:  Eur Radiol       Date:  2013-10-05       Impact factor: 5.315

5.  Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI.

Authors:  Akihiko Matsumine; K Kusuzaki; T Nakamura; S Nakazora; R Niimi; T Matsubara; K Uchida; T Murata; I Kudawara; T Ueda; N Naka; N Araki; M Maeda; A Uchida
Journal:  J Cancer Res Clin Oncol       Date:  2008-12-20       Impact factor: 4.553

6.  Evaluation of (18)F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors.

Authors:  Stephen M Broski; Geoffrey B Johnson; Benjamin M Howe; Mark A Nathan; Doris E Wenger; Robert J Spinner; Kimberly K Amrami
Journal:  Skeletal Radiol       Date:  2016-04-26       Impact factor: 2.199

Review 7.  A-Z of malignant peripheral nerve sheath tumors.

Authors:  S C Kamran; A B Shinagare; S A Howard; J L Hornick; N H Ramaiya
Journal:  Cancer Imaging       Date:  2012-10-26       Impact factor: 3.909

Review 8.  Diagnosis and management of neurofibromatosis type 1.

Authors:  B R Korf
Journal:  Curr Neurol Neurosci Rep       Date:  2001-03       Impact factor: 6.030

9.  Malignant peripheral nerve sheath tumors: differentiation patterns and immunohistochemical features - a mini-review and our new findings.

Authors:  Aitao Guo; Aijun Liu; Lixin Wei; Xin Song
Journal:  J Cancer       Date:  2012-07-04       Impact factor: 4.207

10.  The clinicopathologic spectrum and genomic landscape of de-/trans-differentiated melanoma.

Authors:  Ingrid Ferreira; Alastair Droop; Olivia Edwards; Kim Wong; Victoria Harle; Omar Habeeb; Deepa Gharpuray-Pandit; Joseph Houghton; Katharina Wiedemeyer; Thomas Mentzel; Steven D Billings; Jennifer S Ko; Laszlo Füzesi; Kathleen Mulholland; Ivana Kuzmic Prusac; Bernadette Liegl-Atzwanger; Nicolas de Saint Aubain; Helen Caldwell; Laura Riva; Louise van der Weyden; Mark J Arends; Thomas Brenn; David J Adams
Journal:  Mod Pathol       Date:  2021-06-21       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.